Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing

Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing 

– IMM-BCP-01 already shown to neutralize all other CDC variants of concern in pre-clinical testing

– IND submission planned for this quarter

See more here

Comments are closed.